Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pb(PfCS@UIS4) genetically modified malaria parasite immunization study in healthy volunteers
NL-OMON45576Phase 2Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- May 2017
- Countries
- 1
01
Overview
Phase 2, open-label trial in malaria and Falciparum malaria (PF) (6 arms), sponsored by Radboud University Medical Center. Primary endpoints: Frequency and magnitude of adverse events, Presence of parasitemia after Pb(PfCS@UIS4) exposure and 2 more. Started May 2017; status: active, not recruiting.
02
Conditions
malariaFalciparum malaria (PF)
Beyond the preview
Go deeper on NL-OMON45576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45576.